SCHEMBL18172415

SCHEMBL18172415

CCC(C)(C)NC(=O)c1cc(-c2ccccc2Cl)cc(-n2nnnc2C(C)(C)C)c1

nearest known ligand 0.40

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
HPGD P15428 2/20 0.40
NPC1 O15118 1/20 0.40
RAB9A P51151 1/20 0.40
L3MBTL1 Q9Y468 1/20 0.40
DGAT2 Q96PD7 5/20 0.39
KMT2A Q03164 3/20 0.37
MEN1 O00255 2/20 0.37
ALDH1A1 P00352 2/20 0.37
NPSR1 Q6W5P4 1/20 0.37
CNR1 P21554 2/20 0.35
CNR2 P34972 2/20 0.35
GAA P10253 2/20 0.35
CYP1A2 P05177 1/20 0.35
CYP3A4 P08684 1/20 0.35
TSHR P16473 1/20 0.35
CYP2C19 P33261 1/20 0.35
ANO1 Q5XXA6 1/20 0.34
NAMPT P43490 1/20 0.34
LMNA P02545 1/20 0.34
SCN9A Q15858 1/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL18172364 0.86 P2RX3 (0.39) L3MBTL1CNR1CNR2ANO1
SCHEMBL18172381 0.82 P2RX3 (0.39) DGAT2KMT2AMEN1CNR1CNR2
SCHEMBL18172375 0.79 P2RY14 (0.39) L3MBTL1CNR1CNR2ANO1
SCHEMBL18184246 0.78 CNR2 (0.48) DGAT2CNR1CNR2
SCHEMBL18172409 0.75 P2RY14 (0.42) CNR1CNR2ANO1
SCHEMBL18172474 0.75 P2RX3 (0.42) L3MBTL1KMT2AMEN1CNR1CNR2
SCHEMBL18172497 0.74 CNR2 (0.48) DGAT2CNR1CNR2
SCHEMBL18172441 0.74 P2RY14 (0.40) DGAT2CNR2ANO1SCN9A
SCHEMBL18172475 0.73 P2RX3 (0.42) L3MBTL1ALDH1A1CNR1CNR2GAA
SCHEMBL18172423 0.73 P2RX3 (0.49) HPGDRAB9AKMT2AMEN1ALDH1A1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-3286182-A1 TETRAZOLE DERIVATIVES FOR USE IN THE TREATMENT OF PSYCHIATRIC DISORDERS F. Hoffmann-La Roche AG (CH) 2018-02-28 EP disclosed
WO-2016169902-A1 TETRAZOLE DERIVATIVES FOR USE IN THE TREATMENT OF PSYCHIATRIC DISORDERS F. HOFFMANN-LA ROCHE AG (CH) 2016-10-27 WO disclosed